Accuray | ARAY - Assets


Accuray reported $448.01M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.07B 188.78M Jun/2026
AtriCure USD 676.64M 32.66M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 873.02M 13.58M Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Trinity Biotech USD 105.16M 1.45M Dec/2025